Artwork

Content provided by Beacon Medical Interchange, Drs. Charu Aggarwal, and Jack West. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Beacon Medical Interchange, Drs. Charu Aggarwal, and Jack West or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Dr. Sanjay Popat, Debating With Us Where the Dust Has Settled with Adjuvant Osimertinib After the ADAURA Trial | BTJ-003

48:31
 
Share
 

Manage episode 289345774 series 2906905
Content provided by Beacon Medical Interchange, Drs. Charu Aggarwal, and Jack West. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Beacon Medical Interchange, Drs. Charu Aggarwal, and Jack West or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Co-hosts Charu Aggarwal and Jack West are joined by guest expert Sanjay Popat to discuss how practice should change & open questions on molecular testing & adjuvant EGFR inhibitor osimertinib for resected early stage EGFR mutation-positive NSCLC.

  continue reading

28 episodes

Artwork
iconShare
 
Manage episode 289345774 series 2906905
Content provided by Beacon Medical Interchange, Drs. Charu Aggarwal, and Jack West. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Beacon Medical Interchange, Drs. Charu Aggarwal, and Jack West or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Co-hosts Charu Aggarwal and Jack West are joined by guest expert Sanjay Popat to discuss how practice should change & open questions on molecular testing & adjuvant EGFR inhibitor osimertinib for resected early stage EGFR mutation-positive NSCLC.

  continue reading

28 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide